Moderna Shares Jump 11.7% Amid Bird-Flu Vaccine Interest
Moderna's stock sees an 11.7% rise as U.S. reports first bird-flu fatality, driving demand for its H5N1 vaccine. Explore the impact on vaccine stocks today.
Moderna shares surged 11.7% as reports of the first U.S. bird-flu fatality increased interest in its H5N1 vaccine.